BENEDICTO CRESPO FACORRO

Categoría
Catedrático de Universidad (Pza. V.)

Contacto

Correo electrónico

Departamento

Área
Psiquiatría

Docencia

Investigación

Proyectos y contratos de investigación

SchizOMICS: Estudio multidisciplinar CIBER para optimizar el tratamiento de la esquizofrenia utilizando datos multi-omics y biología de sistemas (ICI21_00089 - Coordinador Work Package)
Clozapina para el tratamiento de psicosis en personas con discapacidad intelectual (ICI19_00026 - Investigador Principal Consolidado)
Sintonizando mundos: neurociencia para adolescentes (FCT-20-16227 - Investigador/a)
CIBER 2007 CRESPO FACORRO, BENEDICTO CB07/09/2001 G-B (00400200101834 - Investigador Principal Consolidado)
The role of ADAMTS2 in schizophrenia: New mechanistic insights into brain functioning and therapeutic perspectives based on mouse and cellular models (P20_00811 - Investigador Principal Consolidado)
CD19/00183 Contrato Sara Borrell (CD19/00183 - Investigador Principal Consolidado)
CM20/00015 Contrato Rio Hortega (CM20/00015 - Investigador Principal Consolidado)
Prevención del riesgo de suicidio en la era post-pandemia COVID-19: Integrando modelos clínicos personalizados y biológicos. (RH-0081-2020 - Investigador Principal Consolidado)
Prevención e Intervención en Suicidio (SURVIVE): estudio de cohorte y ensayos clínicos controlados anidados de programas de prevención secundaria para (PI19/000685 - Investigador/a)
ASESORAMIENTO EN PROTOCOLOS DE INVESTIGACION DE ENSAYOS CLINICOS EN EL AREA TERAPEUTICA DE ESQUIZOFRENIA (Investigador Principal Joven)
Guía de Psicoeducación para las Familias de Personas Diagnosticadas de Psicosis (FC-ESM 2008 - Investigador/a)
Guía para Médicos de Atención Primaria sobre Primeros Episodios de Psicosis (FC-ESM 2010 - Investigador/a)
Estudio de fase 2, aleatorizado, doble ciego, controlado con placebo, para evaluar el efecto de AMG 747, como tratamiento adicional, sobre los síntoma (2011-004844-23 - Investigador/a)
Estudio observacional de cohorte prospectiva de pacientes con síntomas persistentes de esquizofrenia para describir el curso y la carga de la enfermed (ROC-ESQ-2012-01 - Investigador/a)
Estudio observacional, MAP y de 6 semanas de seguimiento para evaluar la variación de la gravedad de la enfermedad en pacientes con esquizofrenia que (AN-PAL-2011-01 - Investigador/a)
ROAC2014. Estudio abierto randomizado de dosis flexibles de la efectividad de antipsicóticos de segunda generación en el tratamiento de pacientes con (2013-005399-16 - Investigador/a)
Estudio observacional para la evaluación del coste/efectividad de la intervención farmacogenética en la optimización del tratamiento con antipsicótico (RCC-ANT-2013-01 - Investigador/a)
EULAST - European Long-acting Antipsychotics in Schizophrenia Trial (Comparing outcome in schizophrenia between different depot antipsychotics and ora (2014-002765-30 - Investigador/a)
Proyecto de Cohortes Primeros Episodios de Psicosis (SAM16PE07 - Investigador/a)
Placebo-controlled trial in subjects at ultra-high risk for psychosis with omega-3 fatty acids in Europe (2015-003503-39 - Responsable)
A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I D (NCT03187769 - Investigador/a)
Aripiprazole once-monthly versus daily oral atypical antipsychotic treatment in patients with recent-onset schizophrenia: an observational, non-interv (NCT03130465 - Investigador/a)
Cannabis y psicosis: estudio de marcadores genéticos y de factores clinicos y cognitivos pronosticos de discapacidad (SCO/3246/2004 - Responsable)
Ensayo clínico de prevención de recaídas en psicosis de inicio reciente: ensayo clínico aleatorizado HUMV/EPPIC (PI050697 - Responsable)
Estudio transversal y longitudinal de la accion de las citocinas en la regulacion de las proteinas de sinapsis en la esquizofrenia. Implicaciones y re (PI050427 - Responsable)
Genetics and Neuroimaging markers for schizophrenia (CI2005-0308007 - Responsable)
Efectos de los fármacos antipsicóticos en la morfometria cortical y subcortical cerebral en primeros episodios de esquizofrenia (PI060507 - Responsable)
Efectos de los fármacos antipsicóticos en la morfometria cortical y subcortical cerebral en primeros episodios de esquizofrenia (Exp.: API07/011). (Exp.: API07/011 - Responsable)
Identificación de un biomarcador asociado a células progenitoras neuronales mediante Espectroscopia de RM: Desarrollo de procesamiento de señales basa (PT79B - Responsable)
Identificación de marcadores moleculares en la esquizofrenia (FLTQ 2009) (FLTQ 2009 - Responsable)
Influencia de variaciones en genes implicados en el neurodesarrollo sobre las alteraciones estructurales cerebrales en primeros episodios de esquizofr (PI10/00183 - Responsable)
Caracterización de genes involucrados en la esquizofrenia mediante análisis de expresión génica y genómica poblacional (FLTQ-2010) (FLTQ-2010 - Responsable)
ROAMER - A Roadmap for Mental Health Research in Europe (HEALTH.2011.3.3-4_Grant agreement no. 282586 - Responsable)
Bases Biopsicosociales de las psicosis y predictors de la respuesta al tratamiento y del curso clínico (Trastornos emocionales y de conducta) (C03-C06 - Responsable)
Morfología Cortical Cerebral en la Esquizofrenia: Estudio transversal y longitudinal de pacientes en las primeras etapas de la enfermedad (PI020499 - Responsable)
Contrato de Intensificacion Investigadores del entorno Sevicio Cántabro de Salud (ISCIII-INT12/235 - Responsable)
ACI 07/03 (ARECES 2006) Investigación genómica en pacientes con un primer episodio de esquizofrenia: identificación de marcadores genéticos y farmacog (ACI 07/03 (ARECES 2006) - Responsable)
Contribución de las variaciones genéticas de nucleótido único (SNPs) en genes candidatos a la ganancia ponderal inducida por antipsicóticos (API 10/13 (API 10/13 - Responsable)
Perfiles de expresión génica y variantes genómicas asociadas con esquizofrenia -Gene expression profiles and genomic variants associated with schizoph (SAF2010-20840-C02-02 - Responsable)
MENTHELDER ¿ Preventing Mental Health-Related Problems In The Elderly (HORIZON 2020; Action group A3 - Action for prevention of functional decline and (- - Responsable)
Comorbilidad entre Enfermedades Neuropsiquiátricas y del Sistema Nervioso Central con el Cáncer (GIEX+COMNPC): Necesidades y Oportunidades para una in (PROMETEO/2011/042 - Responsable)
Red de Innovación en Tecnologías Médicas y Sanitarias (Red ITEMAS). (RD09/0077/00014 - - Responsable)
Red Temática de Investigación Cooperativa en Salud (RETICS) de Biobancos (RD09/0076/00076 - Responsable)
CONTRATO DE INTENSIFICACIÓN (- - Responsable)
EUSARNAD - Joint European and South African Research Network in Anxiety Disorders. Training in methods for epidemiological studies in anxiety disorder (FP7?PEOPLE?2010?IRSES_grant 269213 - Responsable)
CONTRATOS PARA LA INTENSIFICACIÓN DE LA ACTIVIDAD INVESTIGADORA EN EL SNS (ISCIII-INT13/00143 - Responsable)
GEXANT: Nuevos genes candidatos para la respuesta al tratamiento antipsicótico en esquizofrenia: evidencia desde estudios de expresión génica (SAF2013-46292-R - Responsable)
NUEVOS GENES CANDIDATOS PARA LA RESPUESTA AL TRATAMIENTO ANTIPSICÓTICO EN ESQUIZOFRENIA: EVIDENCIA DESDE ESTUDIOS DE EXPRESIÓN GÉNICA (- - Responsable)
Contrato de Intensificacion (ISCIII-INT15/00096 - Responsable)
PRISM Project: Precision medicine comes to Neurosymptomatics (115916 - PRISM Project - Investigador/a)
PLATAFORMA DE INNOVACIÓN EN TECNOLÓGIAS MÉDICAS Y SANITARIAS (- - Responsable)
PLATAFORMA DE BIOBANCOS (- - Responsable)
Contrato de Intensificacion INVESTIGADORES DEL ENTORNO SERVICIO CANTABRO DE SALUD CONV 2016 (- - Responsable)
Desarrollo cerebral y condiciones estresantes tempranas en salud mental: el rol mediador de mecanismos epigenéticos y correlatos de neuroimagen (SAF2015-71526-REDT - Investigador/a)
Solución tecnológica para la prevención de recaídas y la rehabilitación en esquizofrenia (INNVAL16/03 - Responsable)
Understanding Obesity (OB), Metabolic Syndrome (METS), Type 2 Diabetes (T2DM) and Fatty Liver Disease (FL): a multidisciplinary approach (PIE14/00031 - Responsable)
Contrato Predoctoral asociado al proyecto SAF2013-46292-R -Novel candidate genes for treatment response to antipsychotics in schizophrenia: Evidence f (BES-2014-070615 - Responsable)
Contratos Río Hortega de la convocatoria 2016- GRUPO CRESPO-FACORRO (CM16/00034 - Responsable)
Iniciativa de promoción a la investigación europea Valdecilla (VALER H2020) (ECT-2017-0371 - Responsable)
Personalized medicine in HCV infection: understanding and predicting hepatic and systemic responses in the era of the new antiviral drugs (PIE15/00079 - Responsable)
TRATAMIENTO ESTRATIFICADO EN ESQUIZOFRENIA: INTEGRANDO RESULTADOS DE TRANSCRIPTOMA HUMANO Y CELULAR EN LAS ESTRATEGIAS DE TRATAMIENTO ANTIPSICOTICO (SAF2016-76046-R - Responsable)
PLATAFORMA DE UNIDADES DE INVESTIGACIÓN CLÍNICA Y ENSAYOS CLÍNICOS (Scren) (PT17/0017/0039 - Responsable)
Grant agreement no. 603196 - PSYSCAN Translating neuroimaging findings from research into clinical practice (HEALTH.2013.2.2.1-2 - Responsable)
Atmospheric Electricity Network: coupling with the Earth System, climate and biological systems (ELECTRONET) (CA15211 - Investigador/a)
Mapping Heterogeneity of Neuroanatomical Imaging Signatures of Psychosis via Pattern Analysis (1R01MH112070-01A1 - Investigador/a)
PSYCH UP Improving support for people affected by psychological disorders (EU 18/08: VET - Responsable)
Glutamine Metabolism in the Brain Liver axis in NAFLD (UMBRELLA) (UMBRELLA - Responsable)
Enhancing Psychiatric Genetic Counselling, Testing, and Training in Europe (EnGagE) (CA17130 - Investigador/a)
El papel de ADAMTS2 en esquizofrenia: nuevos conocimientos sobre mecanismos cerebrales implicados y perspectivas terapéuticas basado en modelos animal (- - Responsable)

Artículos publicados

Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel;Sánchez-Hidalgo, Ana C.;Cisneros-Herreros, José Miguel;Sainz-, Jesus:
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Frontiers in Pharmacology. 2021. 10.3389/fphar.2021.646701.
Lago, Santiago G;Papiol, Sergi;Suárez-pinilla, Paula;Ruland, Tillmann;Auyeug, Bonnie;Mikova, Olya;Kabacs, Nikolett;Arolt, Volker;Baron-cohen, Simon;Crespo-facorro, Benedicto;Bahn, Sabine;Tomasik, Jakub;Van Rees, Geertje F;Rubey, Marina;González-vioque, Emiliano;Ramsey, Jordan M;Haenisch, Frieder;Broek, Jantine A;Vázquez-bourgon, Javier:
Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior and Immunity. 2021. Vol: 91. Pág. 673-682. 10.1016/j.bbi.2020.07.043.
Rodríguez-pérez, Noelia;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Víctor;Setién-suero, Esther;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Group Study, Pafip:
Long term cortical thickness changes after a first episode of non-affective psychosis: The 10 year follow-up of the PAFIP cohort. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2021. Vol: 108. 10.1016/j.pnpbp.2020.110180.
Murillo-garcía, Nancy;Setién-suero, Esther;Pardo -de Santayana, Guillermo;Murillo-garcía, Marisol;Pelayo -terán, José María;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Entire duration of active psychosis and neurocognitive performance in first-episode non-affective psychosis. Early Intervention In Psychiatry. 2021. Vol: 15. Núm: 5. Pág. 1266-1275. 10.1111/eip.13077.
Izquierdo, Ana;Group Study, Pafip;Cabello, María;De La Torre-luque, Alejandro;Ayesa-arriola, Rosa;Setién-suero, Esther;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Ayuso -mateos, José Luis;Crespo-facorro, Benedicto:
A network analysis approach to functioning problems in first psychotic episodes and their relationship with duration of untreated illness:Findings fro. Journal of Psychiatric Research. 2021. Vol: 136. Pág. 483-491. 10.1016/j.jpsychires.2020.10.019.
Vázquez-bourgon, Javier;Mayoral-van-son, Jacqueline;Gómez-revuelta, Marcos;Juncal-ruíz, María;Ortiz-garcía De La Foz, Víctor;Tordesillas-gutiérrez, Diana;Ayesa-arriola, Rosa;Bioque, Miquel;Crespo-facorro, Benedicto:
Treatment discontinuation impact on long-term (10-years) weight gain andlipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort.. International Journal of Neuropsychopharmacology. 2021. Vol: 24. Núm: 1. Pág. 1-7. 10.1093/ijnp/pyaa066.
Delgado-alvarado, Manuel;Vázquez-bourgon, Javier;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Victor;Mayoral-van Son, Jacqueline;Labad, Javier;Crespo-facorro, Benedicto:
Predictive value of prolactin in first episode psychosis at ten years follow-up. Revista de Psiquiatría y Salud Mental. 2021. Vol: 14. Núm: 3. Pág. 179-180. 10.1016/j.rpsmen.2020.10.002.
Crespo-facorro, Benedicto:
Brief greeting and shared vision. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 53-54. 10.1016/j.rpsm.2020.04.005.
Crespo-facorro, Benedicto:
Mental health and the SARS-CoV-2 pandemic. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 55-56. 10.1016/j.rpsm.2020.04.010.
Crespo, Benedicto:
The synergetic effect of childhood trauma and recent stressful events in psychosis: associated neurocognitive dysfunction. Acta Psychiatrica Scandinavica. 2020. 10.1111/acps.13114.
Crespo, Benedicto:
Brain grey matter abnormalities in first episode non-affective psychosis patients with suicidal behaviours: The role of neurocognitive functioning. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2020. 10.1016/j.pnpbp.2020.109948.
Rodríguez-sánchez, José Manuel;Setién-suero, Esther;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Gil-lópez, Patxi;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa;Grupo, Pafip:
Ten-year course of cognition in first-episode non-affective psychosis patiens:PAFIP cohort. Psychological Medicine. 2020. Pág. 1-10. 10.1017/S0033291720002408.
Crespo, Benedicto:
Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence. Schizophrenia Bulletin. 2020. 10.1093/schbul/sby189.
Crespo-facorro, Benedicto;Newton, Richard;Such, Pedro;Nylander, Anna-greta;Madera, Jessica;Resemann, Henrike K;Worthington, Emma;O¿connor, Molly;Drane, Emma;Steeves, Sara:
The burden of disease in early schizophrenia - a systematic literature review. Journal of Current Medical Research and Opinion. 2020. Vol: 37. Núm: 1. Pág. 109-121. 10.1080/03007995.2020.1841618.
Pardo -de Santayana, Guillermo;Vázquez-bourgon, Javier;Gómez-revuelta, Marcos;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Víctor;Crespo-facorro, Benedicto;Pelayo-terán, José María;Research Group, Pafip:
Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study. Schizophrenia Research. 2020. Vol: 220. Pág. 240-247. 10.1016/j.schres.2020.03.009.
Crespo, Benedicto:
Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain: a journal of neurology. 2020. 10.1093/brain/awaa025.
Pardo-de Santayana, Guillermo;Vázquez-bourgon, Javier;Gómez-revuelta, Marcos;Ayesa-arriola, Rosa;Ortiz-garcía De La Foz, Victor;Crespo-facorro, Benedicto;Pelayo-terán, José María;Research Group, Pafip:
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis . Data in Brief. 2020. Vol: 30. 10.1016/j.dib.2020.105599.
Juncal -ruiz, María;Crespo-facorro, Benedicto;Riesco-davila, Laura;Vázquez-bourgon, Javier;Ortiz-garcia De La Foz, Victor;Mayoral-van Son, Jacqueline;Ayesa-arriola, Rosa;Setién-suero, Esther;Leza-Cerro, Juan Carlos;Lopez-hoyos, Marcos:
Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study. International Journal of Molecular Sciences. 2020. Vol: 21. Núm: 17. 10.3390/ijms21176106.
Tognin, Stefania;Dazzan, Paola;Maat, Arija;De Haan, Lieuwe;Crespo-facorro, Benedicto;Glenthoj, Birte;Lawrie, Stephen M;Mcdonald, Colm;Gruber, Oliver;Van Amelsvoort, Therese;Arango, Celso;Van Hell, Hendrika H;Kircher, Tilo;Nelson, Barnaby;Galderisi, Silvana;Bressan, Rodrigo;Kwon, Jon S;Weiser, Mark;Mizrahi, Romina;Sachs, Gabriele;Maatz, Anke;Kahn, René;Merritt, Kate;Mcguire, Phillip;Consortium, Psyscan;Winter Van Rossum, Inge;Bossong, Matthijs G;Kempton, Matthew J;Modinos, Gemma;Fusar-poli, Paolo;Mechelli, Andrea:
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Re. Schizophrenia Bulletin. 2020. Vol: 46. Núm: 2. Pág. 432-441. 10.1093/schbul/sbz067.
Zhang, Xuan;De Leon-Molina, Jose Alfonso;Crespo-facorro, Benedicto;Diaz, Francisco J:
Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and c. Journal of Biopharmaceutical Statistics. 2020. Vol: 30. Núm: 5. Pág. 916-940. 10.1080/10543406.2020.1765371.
Crespo, Benedicto:
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3- Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzap. International Journal of Neuropsychopharmacology. 2020. 10.1093/ijnp/pyaa004.
Valdés-florido, María José;López-díaz, Álvaro;Palermo-zeballos, Fernanda Jazmín;Martínez-molina, Iván;Martín-gil, Victoria Eugenia;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista de Psiquiatría y Salud Mental. 2020. Vol: 13. Núm: 2. Pág. 90-94. 10.1016/j.rpsm.2020.04.009.
Labad, Javier;Montalvo, Itziar;González-rodríguez, Alexandre;García-rizo, Clemente;Crespo-facorro, Benedicto;Monreal, José Antonio;Palao, Diego:
Data of a meta-analysis on pharmacological treatment strategis for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia. Data in Brief. 2020. Vol: 31. 10.1016/j.dib.2020.105904.
Crespo, Benedicto:
The genetic architecture of the human cerebral cortex. Science. 2020. 10.1126/science.aay6690.
Aliño-dies, María;Monfort-pañego, Manuel;Ayesa-arriola, Rosa;Ruiz-Veguilla, Miguel;Crespo-facorro, Benedicto;Tabarés-seisdedos, Rafael;Sámchez-ortí, Joan Vicent;Correa-ghisays, Patricia;Balanzá-martínez, Vicent;Vila-francés, Joan;Selva-vera, Gabriel;Correa-estrada, Paulina;Forés-martos, Jaume;San- Martín-valenzuela, Constanza:
Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizo. Frontiers in Psychology. 2020. Vol: 11. 10.3389/fpsyg.2020.525231.
Ayesa-arriola, Rosa;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Ortíz-garcía De La Foz, Víctor;Setién-suero, Esther;Ramírez-bonilla, María Luz;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Juncal-ruiz, María;Gómez-revuelta, Marcos:
Understanding sex differences in long-term outcomes after a first episode of psychosis. NPJ Schizophrenia. 2020. 10.1038/s41537-020-00120-5.
Labad, Javier;Montalvo, Itziar;González-rodríguez, Alexandre;García-rizo, Clemente;Crespo-facorro, Benedicto;Monreal, José Antonio;Palao, Diego:
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-. Schizophrenia Research. 2020. Vol: 222. Pág. 88-96. 10.1016/j.schres.2020.04.031.
Canal-rivero, Manuel;Research Group, Pafip;Ruiz-Veguilla, Miguel;Labad, Javier;Ayesa-arriola, Rosa;Vázquez-bourgon, Javier;Mayoral-van Son, Jacqueline;Setién -suero, Esther;Ortiz-garcía De La Foz, Víctor;Crespo-facorro, Benedicto:
Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis. Schizophrenia Research. 2020. Vol: 222. Pág. 462-464. 10.1016/j.schres.2020.06.011.
López-díaz, Álvaro;Ayesa-arriola, Rosa;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research. Biological Psychiatry. 2020. Vol: 89. Núm: 5. Pág. e29-e30. 10.1016/j.biopsych.2020.09.011.
García-dias, Rafael;Mcdonald, Colm;Tordesillas-gutiérrez, Diana;Cannon, Dara;Mothersill, David;Hernaus, Dennis;Morris, Derek;Setién -suero, Esther;Donohoe, Gary;Frisoni, Giovanni;Tronchin, Giulia;Scarpazza, Cristina;Sato, Joao;Marcelis, Machteld;Kempton, Matthew;Van Haren, Neeltje E M;Gruber, Oliver;Mcgorry, Patrick;Amminger, Paul;Mcguire, Philip;Gong, Qiyong;Kahn, René S;Baecker, Lea;Ayesa-arriola, Rosa;Van Amelsvoort, Therese;Ortiz-garcía De La Foz, Victor;Calhoun, Vonce;Cahn, Wiepke;Mechelli, Andrea;Vieira, Sandra;Pinaya, Walter H L;Corvin, Aiden;Redolfi, Alberto;Nelson, Barnaby;Crespo-facorro, Benedicto:
Neuroharmony: A new tool for harmonizing volumetric MRI data from unseen scanners. NeuroImage. 2020. Vol: 220. Núm: 6. Pág. 117-127. 10.1016/j.neuroimage.2020.117127.
Crespo, Benedicto:
Needs of people with psychosis and their caregivers: «In their own voice». Revista de Psiquiatría y Salud Mental. 2020. 10.1016/j.rpsm.2019.11.002.
Ayesa-arriola, Rosa;Gómez-revuelta, Marcos;Tordesillas-gutiérrez, Diana;Crespo-facorro, Benedicto;Ortiz-garcía De La Foz, Víctor;Martínez-garcía, Obdulia;Setién -suero, Esther;Ramírez, María Luz;Suárez-pinilla, Paula;Mayoral-van Son, Jacqueline;Vázquez-bourgon, Javier;Juncal-ruiz, María:
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort - CORRIGENDUM. Psychological Medicine. 2020. Vol: 1. 10.1017/S0033291719003179.
Vázquez-bourgon, Javier;Ibáñez-alario, Miguel;Mayoral-van Son, Jacqueline;Gómez-revuelta, Marcos;Ayesa-arriola, Rosa;Juncal-ruiz, María;Ortíz-garcía De La Foz, Victor;Crespo-facorro, Benedicto:
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis. European Neuropsychopharmacology. 2020. Vol: 39. Pág. 46-55. 10.1016/j.euroneuro.2020.08.009.
Setién-suero, Esther;Suárez-pinilla, Paula;Ferro, Adele;Tabarés-seisdedos, Rafael;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Childhood trauma and substance use underlying psychosis: a systematic review. European Journal of Psychotraumatology. 2020. Vol: 11. Núm: 1. 10.1080/20008198.2020.1748342.
Cuadrado, Antonio;Cabezas, Joaquín;Llerena, Susana;Nieves-salceda, Juan Francisco;Fortea, José Ignacio;Crespo-facorro, Benedicto;Crespo, Javier:
Prevalence of hepatitis C in patiens with non-affective psychotic disorders. Revista Española de Enfermedades Digestivas. 2020. Vol: 112. Núm: 7. Pág. 550-554. 10.17235/reed.2020.7278/2020.
Crespo, Benedicto:
Verbal memory and voxel based morphometry in first episode non-affective psychosis: A process oriented approach. Neuropsychology. 2019. 10.1037/neu0000540.
Correa-ghisays, Patricia;Vivas-lalinde, Juliana;Conforte-molina, Candela;San-martín, Constanza;Martínez-Pérez, Carlos;Fuentes-durá, Inmaculada;Crespo-facorro, Benedicto;Tabarés-seisdedos, Rafael;Sánchez-ortí, Joan Vicent;Ayesa-arriola, Rosa;Setién-suero, Esther;Balanzá-martínez, Vicent;Selva-vera, Gabriel;Ruiz -ruiz, Juan Carlos;Vila-francés, Joan;Martínez-aran, Anabel:
Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow. Journal of Affective Disorders. 2019. Vol: 257. Pág. 31-37. 10.1016/j.jad.2019.06.059.
Crespo, Benedicto:
Differences between psychiatric disorders in the clinical and functional effectiveness of an acute psychiatric day hospital, for acutely ill psychiatr. Revista de Psiquiatría y Salud Mental. 2019. 10.1016/j.rpsm.2019.04.001.
Crespo, Benedicto:
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data in Brief. 2019. 10.1016/j.dib.2019.104415.
Crespo, Benedicto:
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. JAMA Psychiatry. 2019. 10.1001/jamapsychiatry.2019.0304.
Garro-Martínez, E;Lopez , Juan Francisco;Crespo, Benedicto:
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Translational Psychiatry. 2019. Vol: 9. Núm: 1. 10.1038/s41398-019-0647-7.
Setién-suero, Esther;Neergaard, K.;Ortiz-garcía De La Foz, Víctor;Suárez-pinilla, Paula;Martinez-garcía, O.;Crespo-facorro, Benedicto;Ayesa-arriola, Rosa:
Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 4. Pág. 349-359. 10.1111/acps.13081.
Crespo, Benedicto:
10Kin1day: A Bottom-Up Neuroimaging Initiative. Frontiers in Neurology. 2019. 10.3389/fneur.2019.00425.
López-díaz, A;Fernández-gonzález, J. L.;Lara, I.;Crespo-facorro, Benedicto;Ruiz-Veguilla, Miguel:
The prognostic role of catatonia, hallucinations, and symptoms of schizophrenia in acute and transient psychosis. Acta Psychiatrica Scandinavica. 2019. Vol: 140. Núm: 6. Pág. 574-585. 10.1111/acps.13092.
Crespo, Benedicto:
Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. 2019. 10.1038/s41588-019-0511.
Crespo, Benedicto:
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Science Advances. 2019. 10.1126/sciadv.aau9093.
Crespo, Benedicto:
Multimodal Integration of Brain Images for MRI-Based Diagnosis in Schizophrenia. Frontiers in Neuroscience. 2019. 10.3389/fnins.2019.01203.
Crespo, Benedicto:
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic revie. European Psychiatry. 2019. 10.1016/j.eurpsy.2019.04.009.
Gallardo-ruiz, Ruth;Crespo-facorro, Benedicto;Setién-suero, Esther;Tordesillas-gutiérrez, Diana:
Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review. Psychiatry Investigation. 2019. Vol: 16. Núm: 5. Pág. 336-345. 10.30773/pi.2019.02.10.1.
Crespo, Benedicto:
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort. Psychological Medicine. 2019. 10.1017/S0033291719003179.
Crespo, Benedicto:
Sex differences in gene expression related to antipsychotic induced weight gain. PLoS ONE. 2019. 10.1371/journal.pone.0215477.
Crespo, Benedicto:
Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study. The European Respiratory Journal. 2019. 10.1183/13993003.congress-2019.PA4335.
Crespo, Benedicto:
PMH12 THE COST OF RELAPSES MANAGEMENT IN PATIENTS SUFFERING FROM SCHIZOPHRENIA IN ITALY AND SPAIN: COMPARISON BETWEEN LURASIDONE AND QUETIAPINE XR.. Value in Health. 2019. 10.1016/j.jval.2019.09.1486.
Crespo, Benedicto:
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. 2019. 10.1176/appi.ajp.2018.17121363.
Crespo, Benedicto:
Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis. Psychological Medicine. 2019. 10.1017/S0033291719003568.
Crespo, Benedicto:
Altered gene expression in antipsychotic-induced weight gain. NPJ Schizophrenia. 2019. 10.1038/s41537-019-0075-y.
Crespo, Benedicto:
Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain, Behavior and Immunity. 2019. 10.1016/j.bbi.2019.05.015.
Crespo, Benedicto:
Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing. Schizophrenia Research. 2019. 10.1016/j.schres.2019.01.032.
Salagre, Estela;González-pinto, Ana;Haro, Josep María;Leza, Juan Carlos;Mckenna, Peter J.;Meana, Jose Javier;Menchón, José Manuel;Micó-Segura, Juan Antonio;Palomo, Tomás;Pazos, Ángel;Pérez, Victor;Arango, Celso;Saiz-ruiz, Jerónimo;Sanjuán, Julio;Tabarés-seisdedos, Rafael;Crespo, Benedicto;Casas, Miquel;Vilella, Elisabet;Palao, Diego;Olivares, Jose Manuel;Rodriguez-Jimenez, Roberto;Vieta, Eduard;Artigas, Francesc;Ayuso-mateos, José Luis;Bernardo, Miquel;Castro-fornieles, Josefina;Bobes, Julio;Desco, Manuel;Fañanás, Lourdes:
CIBERSAM: Ten years of collaborative translational research in mental disorders.. Revista de Psiquiatría y Salud Mental. 2019. Vol: 12. Núm: 1. Pág. 1-8. 10.1016/j.rpsm.2018.10.001.
Crespo, Benedicto:
Personality traits, theory of mind and their relationship with multiple suicide attempts in a sample of first episode psychosis patients: One-year fol. Journal of Affective Disorders. 2019. 10.1016/j.jad.2019.05.078.
Crespo, Benedicto:
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients.Progres. Progress in Nneuro-Psychopharmacology & Biological Psychiatry. 2019. 10.1016/j.pnpbp.2019.109677.
Crespo, Benedicto:
Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study. Journal of Psychopharmacology. 2019. 10.1177/0269881118822173.
Crespo, Benedicto:
The dynamic relationship between insight and suicidal behavior in first episode psychosis patients over 3-year follow-up. European Neuropsychopharmacology. 2018.
Crespo, Benedicto:
Long-term antipsychotic effectiveness in First Episode of Psychosis: a 3-year follow-up randomized clinical trial comparing aripiprazole, quetiapine a. International Journal of Neuropsychopharmacology. 2018.
Crespo, Benedicto:
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks. Molecular Psychiatry. 2018. 10.1038/s41380-018-0123-4.
Crespo, Benedicto:
Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Molecular Psychiatry. 2018.
Crespo, Benedicto:
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. 2018.
Crespo, Benedicto:
Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up. Schizophrenia Research. 2018.
Crespo, Benedicto:
Predicting suicidal behaviour after first episode of non-affective psychosis: The role of neurocognitive functioning. European Psychiatry. 2018. 10.1016/j.eurpsy.2018.06.001.
Crespo, Benedicto:
correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework.. BMC Genomics. 2018.
Crespo, Benedicto:
Blood Gene Expression Profile Predicts Response to Antipsychotics. Frontiers in Molecular Neuroscience. 2018.
Crespo, Benedicto:
Understanding the Direct and Indirect Costs of a First Episode of Psychosis Program: Insights From PAFIP of Cantabria, Spain, During the First Year of. Early Intervention In Psychiatry. 2018.
Crespo, Benedicto:
Suicidal Behavior and Personality Traits Contribute to Disability in First-episode Psychosis: A 1-Year Follow-up Study. Suicide and Life-Threatening Behavior. 2018.
Ruderfer, Douglas M;Crespo, Benedicto;Guzman-Parra, Jose:
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018. Vol: 173. Núm: 7. Pág. 1705-1715. 10.1016/j.cell.2018.05.046..
Crespo, Benedicto:
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. The American Journal of Gastroenterology. 2018. 10.1038/s41395-018-0157-x.
Crespo, Benedicto;Agraz, Antonio Manuel:
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget. 2018. Vol: 9. Núm: 56. Pág. 30869-30882. 10.18632/oncotarget.25766.
Crespo, Benedicto:
The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals. Journal of Neuroinflammation. 2018.
Crespo, Benedicto:
Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression. Schizophrenia Research. 2018.
Crespo, Benedicto:
Duration of active psychosis and functional outcomes in first-episode non-affective psychosis. European Psychiatry. 2018.
Crespo, Benedicto;Comino-Méndez, I:
Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genetics In Medicine. 2018. Vol: 20. Núm: 12. Pág. 1644-1651. 10.1038/s41436-018-0003-y.
Crespo, Benedicto:
The right occipital lobe and poor insight in first-episode psychosis. PLoS ONE. 2018.
Crespo, Benedicto:
Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients. Archives of Women's Mental Health. 2018.
Crespo, Benedicto:
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. British Journal of Psychiatry. 2018.
Newton, Richard;Rouleau, Alice;Nylander, Anna-greta;Loze, Jena-yves;Resemann, Henrike K.;Steeves, Sara;Crespo-facorro, Benedicto:
Diverse definitions of the early course of schizophrenia- a targeted literature review. NPJ Schizophrenia. 2018. Vol: 4. Núm: 1. 10.1038/s41537-018-0063-7.
Crespo, Benedicto:
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Revista de Psiquiatría y Salud Mental. 2018.
Crespo, Benedicto:
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta An. Biological Psychiatry. 2018.
Crespo, Benedicto:
Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients. The World Journal of Biological Psychiatry. 2018.
Crespo, Benedicto:
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 2018.
Crespo, Benedicto:
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature . Biological Psychiatry. 2018. 10.1016/j.biopsych.2018.10.003.
Antilla, V;Rivera-Sánchez, Margarita;Crespo, Benedicto;Guzman-Parra, Jose:
Analysis of shared heritability in common disorders of the brain. Science. 2018. Vol: 360. Núm: 6395. 10.1126/science.aap8757.
Crespo, Benedicto:
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized. Schizophrenia Research. 2018.
Crespo, Benedicto:
Evaluation of verbal inhibitory control with the Stroop Test in early episodes of psychosis with the experience of traumatic events in infancy. Revista de Neurología. 2018.
Crespo, Benedicto:
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics. 2017.
Crespo, Benedicto:
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. 2017.
Crespo, Benedicto:
Deep brain stimulation and treatment-resistant obsessive-compulsive disorder: A systematic review. Revista de Psiquiatría y Salud Mental. 2017.
Crespo, Benedicto:
Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.. Schizophrenia Research. 2017.
Crespo, Benedicto:
Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Tr. PLoS ONE. 2017.
Crespo, Benedicto:
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychoti. Psychopharmacology. 2017.
Crespo, Benedicto:
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.. Frontiers in Neuroendocrinology. 2017.
Crespo, Benedicto:
Longitudinal investigation of the parietal lobe anatomy in bipolar disorder and its association with general functioning.. Psychiatry Research. 2017.
Crespo, Benedicto:
Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences. PLoS ONE. 2017.
Crespo, Benedicto:
Tobacco smoking and its association with cognition in first episode psychosis patients.. Schizophrenia Research. 2017.
Lopez , Juan Francisco;Crespo, Benedicto:
Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy. Schizophrenia Research. 2017. Vol: 189. Pág. 217-218. 10.1016/j.schres.2017.02.005.
Crespo, Benedicto:
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. 2017.
Pilar-cuéllar, Fuencisla;Brosda, Jan;Romero, Beatriz;Crespo, Benedicto;Pazos, Ángel;Vidal, Rebeca;Díaz, Álvaro;Garro-Martínez, E;Linge, Raquel;Castro, Elena;Haberzettl, Robert;Fink, Heidrun;Bert, Bettina:
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation. ACS Chemical Neuroscience. 2017. Vol: 8. Núm: 11. Pág. 2393-2401. 10.1021/acschemneuro.7b00156.
Crespo, Benedicto:
Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-. Journal of Affective Disorders. 2017. 10.1016/j.jad.2017.03.041.
Crespo, Benedicto:
When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.. Revista de Psiquiatría y Salud Mental. 2017.
Crespo, Benedicto:
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective 034e6f20e971b17fe5ad3d6d. Schizophrenia Research. 2017. 10.1016/j.schres.2017.01.046.
Crespo, Benedicto:
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 2017.
Crespo, Benedicto:
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non. Psychopharmacology. 2017.
Crespo, Benedicto:
Novel genetic loci associated with hippocampal volume. Nature Communications. 2017.
Caballero-Díaz, Francisco Felix;Crespo, Benedicto:
Disability multilevel modelling in first episodes of psychosis at 3-year follow-up. Schizophrenia Research. 2017. 10.1016/j.schres.2016.12.014.
Crespo-facorro, Benedicto;Ayesa -arriola, Rosa;Ortiz-garcía De La Foz, Victor;Suárez-pinilla, Paula;Valdizan, Elsa M;Pérez-iglesias, Rocío;Amado-señaris, José Antonio;García-unzueta, M. Teresa;Labad, Javier;Correll, Christopher:
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffectivepsychosis: Analysis of a . Schizophrenia Research. 2017. Vol: 189. Pág. 134-141. 10.1016/j.schres.2017.01.046.
Crespo, Benedicto:
Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition. Schizophrenia Research. 2017.
Crespo, Benedicto:
Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies. Systematic Reviews. 2017.
Crespo, Benedicto:
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics. 2016.
Crespo, Benedicto:
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.. Nature Neuroscience. 2016.
Crespo, Benedicto:
Towards a blood-based diagnostic panel for bipolar disorder.. Brain, Behavior and Immunity. 2016.
Crespo, Benedicto:
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP). European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Crespo, Benedicto:
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. Revista de Psiquiatría y Salud Mental. 2016.
Crespo, Benedicto:
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.. European Archives Of Psychiatry And Clinical Neuroscience. 2016.
Crespo, Benedicto:
Homocysteine and cognition: A systematic review of 111 studies. Neuroscience & Biobehavioral Reviews. 2016.
Crespo, Benedicto:
Environmental factors linked to depression vulnerability are associated with altered cerebellar resting-state synchronization.. Scientific Reports. 2016.
Crespo, Benedicto:
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging and Behavior. 2016.
Crespo, Benedicto:
Schizophrenia risk from complex variation of complement component 4.. Nature. 2016.
Crespo, Benedicto:
Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-u. Frontiers in Psychology. 2016.
Crespo, Benedicto:
Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients. NeuroImage. 2016.
Crespo, Benedicto:
Novel genetic loci underlying human intracranial volume identified through genome-wide association.. Nature Neuroscience. 2016.
Crespo, Benedicto:
Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia.. Frontiers in Psychology. 2016.
Crespo, Benedicto:
Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis. International Journal of Neuropsychopharmacology. 2016.
Crespo, Benedicto:
Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. JAMA Psychiatry. 2016.
Crespo, Benedicto:
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Revista de Psiquiatría y Salud Mental. 2016. 10.1016/j.rpsm.2016.09.001.
Morlan-coarasa, Maria Jose;Arias-loste, María Teresa;Ortíz-garcía De La Foz, Victor;Martínez-garcía, Obdulia;Alonso-martin, Carmen;Crespo, Javier;Romero-Gómez, Manuel;Fábrega, Emilio;Crespo, Benedicto:
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year pros. Psychopharmacology. 2016. Vol: 233. Núm: 23-24. Pág. 3947-3952.
Crespo, Benedicto:
Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year na. Journal of Clinical Psychiatry. 2016.
Crespo, Benedicto:
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurology and Therapy. 2016.
Crespo, Benedicto:
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos. Revista de Psiquiatría y Salud Mental. 2016.
Crespo, Benedicto:
The effects of tobacco smoking on age of onset of psychosis and psychotic symptoms in a first-episode psychosis population. Addiction. 2016.
Crespo, Benedicto:
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. Psychiatry Research. 2015.
Crespo, Benedicto:
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of . Brain Imaging and Behavior. 2015.
Crespo, Benedicto:
Inpatient treatment for anorexia nervosa: a systematic review of randomized controlled trials.. Journal of Psychiatric Practice. 2015.
Crespo, Benedicto:
Effect of DISC1 polymorphisms on the long-term course of neurocognitive deficits in non-affective psychosis. European Psychiatry. 2015.
Crespo, Benedicto:
Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins. PLoS ONE. 2015.
Crespo, Benedicto:
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.. Current Neuropharmacology. 2015.
Crespo, Benedicto:
A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).. Maturitas. 2015.
Crespo, Benedicto:
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.. Translational Psychiatry. 2015.
Crespo, Benedicto:
Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors. European Neuropsychopharmacology. 2015.
Crespo, Benedicto:
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.. The American Journal of Psychiatry. 2015.
Crespo, Benedicto:
Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study. Schizophrenia Research. 2015.
Crespo, Benedicto:
Season of birth and subclinical psychosis: Systematic review and meta-analysis of new and existing data.. Psychiatry Research. 2015.
Crespo, Benedicto:
No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic re. Psychological Medicine. 2015. 10.1017/S0033291715000811.
Crespo, Benedicto:
Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.. Cognitive Neuropsychiatry. 2015.
Crespo, Benedicto:
Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.. Frontiers in Physiology. 2015.
Crespo, Benedicto:
Progressive Structural Brain Changes and NRG1 Gene Variants in First-Episode Nonaffective Psychosis.. Neuropsychobiology. 2015.
Crespo, Benedicto:
Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics. International Journal of Neuropsychopharmacology. 2015.
Crespo, Benedicto:
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics. 2015.
Crespo, Benedicto:
A cross-sectional and longitudinal structural magnetic resonance imaging study of the post-central gyrus in first-episode schizophrenia patients. Psychiatry Research. 2015.
Crespo, Benedicto:
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.. Molecular Psychiatry. 2015.
Crespo, Benedicto:
Common genetic variants influence human subcortical brain structures. Nature. 2015.
Crespo, Benedicto:
Disability in bipolar I disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0. Journal of Affective Disorders. 2015.
Crespo, Benedicto:
Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences. European Psychiatry. 2015.
Crespo, Benedicto:
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.. Psychological Medicine. 2014. 10.1017/S0033291713000330.
Crespo, Benedicto:
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. Psychological Medicine. 2014. 10.1017/S0033291713002365.
Crespo, Benedicto:
Inflammatory and immune response genes have significantly altered expression in schizophrenia. Molecular Psychiatry. 2013. 10.1038/mp.2012.165.
Crespo, Benedicto;Mata-Pastor, Ignacio:
Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features.. Psychological Medicine. 2011. Vol: 41. Núm: 7. Pág. 1449-1460. http://dx.doi.org/10.1017/S003329171000200X.
Mata-Pastor, Ignacio;Crespo, Benedicto:
Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage. 2010. Vol: 53. Núm: 3. Pág. 1016-1020. http://dx.doi.org/10.1016/j.neuroimage.2009.11.010.

Patentes

Crespo, Benedicto: METHOD FOR PREDICTING THE THERAPEUTIC RESPONSE TO ANTIPSYCHOTIC DRUGS. Número de patente:
Crespo, Benedicto: Método de monitorización de tratamiento antipsicótico. Número de patente:

Tesis dirigidas o codirigidas

(Doctorando no grabado):
Prevención de recaídas en primeros episodios psicóticos: Análisis comparativo de efectividad psicofarmacológica. Tesis Doctoral. 2020
(Doctorando no grabado):
Mechanisms controlling the clinical response genes to antipsychotics:role of D1 receptor-CAMP/CREB signalling in the regulation of ADAMTS2. Tesis Doctoral. 2019
Juncal-ruiz, María:
Respuesta inmunoinflamatoria sistémica en primeros episodios de psicosis. Tesis Doctoral. 2018
Sainz-olavarria, María Teresa:
ESTUDIO TRANSVERSAL Y LONGITUDINAL DE LA MORFOMETRÍA DE LA CORTEZA ORBITOFRONTAL EN PACIENTES CON UN PRIMER EPISODIO DE PSICOSIS NO AFECTIVA. RELACIÓN. Tesis Doctoral. 2017
Tordesillas-gutiérrez, Diana:
Diferencias en Volumen de Materia Gris en Pacientes con un Primer Episodio Psicótico y Efectos de Edad de Inicio Utilizando Morfometría Basada en Vóxe. Tesis Doctoral. 2016
Vazquez-bourgon, Javier:
DISC1 y Psicosis No Afectiva: Variaciones en Endofenotipos y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2016
Mayoral, Jacqueline:
Estudio Longitudinal de la Evolución Clínica en Pacientes que, tras un Unico Espisodio de Psicosis no Afectiva, han Alcanzado una Recuperación Complet. Tesis Doctoral. 2016
Suárez-pinilla, Paula:
CAMBIOS MORFOLOGICOS CEREBRALES EN PRIMEROS EPISODIOS DE PSICOSIS NO AFECTIVA:IMPLICACION DE VARIACIONES DE LOS POLIMORFISMOS BDNF, NRG1,CNR1. Tesis Doctoral. 2015
(Doctorando no grabado):
Aplicaciones de la Imagen Médica en Psiquiatría: Un Estudio Transversal y Longitudinal en Primeros Episodios Psicóticos. Tesis Doctoral. 2014
Varela-gómez, Noemí:
Variaciones en el Gen de la Disbindina y su Relación con Sintomatología, Cognición y Neuroimagen en Pacientes con Primer Episodio de Psicosis No Afect. Tesis Doctoral. 2013
Quintero-uribe, Luis Carlos:
Estudio Morfométrico del Lóbulo de la Insula y del Polo Temporal en Individuos con un Primer Episodio de Psicosis No Afectiva: Estudio Transversal y L. Tesis Doctoral. 2012
Pelayo, José María:
Polimorfismo Va1158met del Gen Catecol-O-Metiltransferasa y Características Clínicas en Primeros Episodios de Psicosis. Tesis Doctoral. 2011
Ayesa, Rosa:
Estudio Multidimensional de Predictores de Insight en Primeros Episodios de Psicosis. Tesis Doctoral. 2010
(Doctorando no grabado):
Tratamiento Psicológico para la Prevención de Recaídas en Primeros Episodios de Psicosis.. Tesis Doctoral. 2009
Morelli, Chiara:
FENOMENOLOGIA E CORRELAZIONI CLINICHE DELL'INSIHGT NELL'ESORDIO PSICOTICO: PROGRAMMA PAFIP. Tesis Doctoral. 2009
(Doctorando no grabado):
Procesos Cognitivos en Primeros Episodios de Trastornos del Espectro Esquizofrénico: Un Estudio Longitudinal.. Tesis Doctoral. 2008